Literature DB >> 31578081

Anti-Inflammatory Effects of HDL (High-Density Lipoprotein) in Macrophages Predominate Over Proinflammatory Effects in Atherosclerotic Plaques.

Panagiotis Fotakis1, Vishal Kothari2, David G Thomas1, Marit Westerterp1,3, Matthew M Molusky1, Elissa Altin1, Sandra Abramowicz1, Nan Wang1, Yi He2, Jay W Heinecke2, Karin E Bornfeldt2,4, Alan R Tall1.   

Abstract

OBJECTIVE: HDL (high-density lipoprotein) infusion reduces atherosclerosis in animal models and is being evaluated as a treatment in humans. Studies have shown either anti- or proinflammatory effects of HDL in macrophages, and there is no consensus on the underlying mechanisms. Here, we interrogate the effects of HDL on inflammatory gene expression in macrophages. Approach and
Results: We cultured bone marrow-derived macrophages, treated them with reconstituted HDL or HDL isolated from APOA1Tg;Ldlr-/- mice, and challenged them with lipopolysaccharide. Transcriptional profiling showed that HDL exerts a broad anti-inflammatory effect on lipopolysaccharide-induced genes and proinflammatory effect in a subset of genes enriched for chemokines. Cholesterol removal by POPC (1-palmitoyl-2-oleoyl-glycero-3-phosphocholine) liposomes or β-methylcyclodextrin mimicked both pro- and anti-inflammatory effects of HDL, whereas cholesterol loading by POPC/cholesterol-liposomes or acetylated LDL (low-density lipoprotein) before HDL attenuated these effects, indicating that these responses are mediated by cholesterol efflux. While early anti-inflammatory effects reflect reduced TLR (Toll-like receptor) 4 levels, late anti-inflammatory effects are due to reduced IFN (interferon) receptor signaling. Proinflammatory effects occur late and represent a modified endoplasmic reticulum stress response, mediated by IRE1a (inositol-requiring enzyme 1a)/ASK1 (apoptosis signal-regulating kinase 1)/p38 MAPK (p38 mitogen-activated protein kinase) signaling, that occurs under conditions of extreme cholesterol depletion. To investigate the effects of HDL on inflammatory gene expression in myeloid cells in atherosclerotic lesions, we injected reconstituted HDL into Apoe-/- or Ldlr-/- mice fed a Western-type diet. Reconstituted HDL infusions produced anti-inflammatory effects in lesion macrophages without any evidence of proinflammatory effects.
CONCLUSIONS: Reconstituted HDL infusions in hypercholesterolemic atherosclerotic mice produced anti-inflammatory effects in lesion macrophages suggesting a beneficial therapeutic effect of HDL in vivo.

Entities:  

Keywords:  cholesterol; high-density lipoprotein; inflammation; macrophages; rHDL infusion

Mesh:

Substances:

Year:  2019        PMID: 31578081      PMCID: PMC6879856          DOI: 10.1161/ATVBAHA.119.313253

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  76 in total

Review 1.  Time to ditch HDL-C as a measure of HDL function?

Authors:  Graziella E Ronsein; Jay W Heinecke
Journal:  Curr Opin Lipidol       Date:  2017-10       Impact factor: 4.776

2.  The molecular basis for selective inhibition of unconventional mRNA splicing by an IRE1-binding small molecule.

Authors:  Benedict C S Cross; Peter J Bond; Pawel G Sadowski; Babal Kant Jha; Jaroslav Zak; Jonathan M Goodman; Robert H Silverman; Thomas A Neubert; Ian R Baxendale; David Ron; Heather P Harding
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-06       Impact factor: 11.205

3.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features.

Authors:  Yang Liao; Gordon K Smyth; Wei Shi
Journal:  Bioinformatics       Date:  2013-11-13       Impact factor: 6.937

4.  Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4.

Authors:  Mark Gilchrist; Vesteinn Thorsson; Bin Li; Alistair G Rust; Martin Korb; Jared C Roach; Kathleen Kennedy; Tsonwin Hai; Hamid Bolouri; Alan Aderem
Journal:  Nature       Date:  2006-05-11       Impact factor: 49.962

5.  Targeting IRE1 with small molecules counteracts progression of atherosclerosis.

Authors:  Ozlem Tufanli; Pelin Telkoparan Akillilar; Diego Acosta-Alvear; Begum Kocaturk; Umut Inci Onat; Syed Muhammad Hamid; Ismail Çimen; Peter Walter; Christian Weber; Ebru Erbay
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-30       Impact factor: 11.205

6.  Major lipids, apolipoproteins, and risk of vascular disease.

Authors:  Emanuele Di Angelantonio; Nadeem Sarwar; Philip Perry; Stephen Kaptoge; Kausik K Ray; Alexander Thompson; Angela M Wood; Sarah Lewington; Naveed Sattar; Chris J Packard; Rory Collins; Simon G Thompson; John Danesh
Journal:  JAMA       Date:  2009-11-11       Impact factor: 56.272

7.  Novel formulation of a reconstituted high-density lipoprotein (CSL112) dramatically enhances ABCA1-dependent cholesterol efflux.

Authors:  Svetlana Diditchenko; Andreas Gille; Ingo Pragst; Dominik Stadler; Marcel Waelchli; Ross Hamilton; Andrew Leis; Samuel D Wright
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-07-18       Impact factor: 8.311

Review 8.  Apoptosis signal-regulating kinase 1 in stress and immune response.

Authors:  Kohsuke Takeda; Takuya Noguchi; Isao Naguro; Hidenori Ichijo
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

9.  ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats.

Authors:  Hideki Nishitoh; Atsushi Matsuzawa; Kei Tobiume; Kaoru Saegusa; Kohsuke Takeda; Kiyoshi Inoue; Seiji Hori; Akira Kakizuka; Hidenori Ichijo
Journal:  Genes Dev       Date:  2002-06-01       Impact factor: 11.361

10.  CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer.

Authors:  Cameron R Stewart; Lynda M Stuart; Kim Wilkinson; Janine M van Gils; Jiusheng Deng; Annett Halle; Katey J Rayner; Laurent Boyer; Ruiqin Zhong; William A Frazier; Adam Lacy-Hulbert; Joseph El Khoury; Douglas T Golenbock; Kathryn J Moore
Journal:  Nat Immunol       Date:  2009-12-27       Impact factor: 25.606

View more
  33 in total

1.  HDL in Morbidity and Mortality: A 40+ Year Perspective.

Authors:  Alan R Tall
Journal:  Clin Chem       Date:  2021-01-08       Impact factor: 8.327

2.  HDL and ASCVD.

Authors:  Hongtu Cui; Qian Du
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

3.  Role of neutrophils in type 2 diabetes and associated atherosclerosis.

Authors:  W Coles Keeter; Alina K Moriarty; Elena V Galkina
Journal:  Int J Biochem Cell Biol       Date:  2021-10-13       Impact factor: 5.085

4.  Ultra-fast proteomics with Scanning SWATH.

Authors:  Christoph B Messner; Vadim Demichev; Nic Bloomfield; Jason S L Yu; Matthew White; Marco Kreidl; Anna-Sophia Egger; Anja Freiwald; Gordana Ivosev; Fras Wasim; Aleksej Zelezniak; Linda Jürgens; Norbert Suttorp; Leif Erik Sander; Florian Kurth; Kathryn S Lilley; Michael Mülleder; Stephen Tate; Markus Ralser
Journal:  Nat Biotechnol       Date:  2021-03-25       Impact factor: 54.908

Review 5.  APOA1: a Protein with Multiple Therapeutic Functions.

Authors:  Blake J Cochran; Kwok-Leung Ong; Bikash Manandhar; Kerry-Anne Rye
Journal:  Curr Atheroscler Rep       Date:  2021-02-16       Impact factor: 5.113

6.  Macrophage Responses to Environmental Stimuli During Homeostasis and Disease.

Authors:  Adil Rasheed; Katey J Rayner
Journal:  Endocr Rev       Date:  2021-07-16       Impact factor: 19.871

Review 7.  HDL in Immune-Inflammatory Responses: Implications beyond Cardiovascular Diseases.

Authors:  Fabrizia Bonacina; Angela Pirillo; Alberico L Catapano; Giuseppe D Norata
Journal:  Cells       Date:  2021-04-29       Impact factor: 6.600

8.  Response by Fotakis et al to Letter Regarding Article, "Anti-Inflammatory Effects of HDL (High-Density Lipoprotein) in Macrophages Predominate Over Proinflammatory Effects in Atherosclerotic Plaques".

Authors:  Panagiotis Fotakis; Vishal Kothari; Karin E Bornfeldt; Alan R Tall
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-01-22       Impact factor: 8.311

Review 9.  Immune-based therapies in cardiovascular and metabolic diseases: past, present and future.

Authors:  Andrew J Murphy; Mark A Febbraio
Journal:  Nat Rev Immunol       Date:  2021-07-20       Impact factor: 53.106

10.  HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research.

Authors:  Anand Rohatgi; Marit Westerterp; Arnold von Eckardstein; Alan Remaley; Kerry-Anne Rye
Journal:  Circulation       Date:  2021-06-07       Impact factor: 39.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.